Pharmaron at CPhI Milan 2024

Pharmaron had the pleasure of attending CPhI Milan 2024 as an exhibitor from October 8-10, where our team engaged with an energetic community of industry leaders, innovators, and collaborators. 

One of the highlights of our presence at CPhI was Dr. Paul Quigley, Director of Process Development and Manufacturing, who gave a video overview of Pharmaron’s robust and integrated CMC capabilities. Dr. Quigley shared that the event saw exceptional attendance, with a strong interest in Pharmaron’s science-driven approach and commitment to high-quality solutions for clients’ CMC needs. “It was particularly rewarding to receive enthusiastic feedback from our existing clients,” he noted. One established consultant even shared that Pharmaron stood out as his top choice among more than 100 CDMO/CRO providers—a powerful testament to our dedication to quality and reliability. 

Watch Dr. Quigley’s Video Overview Here: 

The Pharmaron team also connected with numerous familiar faces, with Dave Thomas, senior director of Strategic Partnerships, CMC, sharing his thoughts on the event’s value. “CPhI offers a unique opportunity to meet both new and existing clients face-to-face in a vibrant environment,” said Thomas. It’s the perfect setting to showcase our latest capabilities and innovations developed over the past year.” 

The success of CPhI Milan 2024 goes beyond forging new connections; it also underscores our commitment to deepening relationships with our valued clients. We take pride in our seven global research and manufacturing facilities, which empower us to support clients worldwide with clinical development and commercial-scale capabilities across China, the UK, and the US. 

Thank you to everyone who visited our booth and contributed to this unforgettable experience.